186 Andelen af patienter, som udvikler antistoffer mod etanercept i langtidsundersøgelser (af op til 3, 5 års varighed) stiger over tid som forventet.
The proportion of subjects who developed antibodies to etanercept in longer-term trials (of up to 3.5 years) increases over time, as expected.